Company / Net Income
Verrica Pharmaceuticals Inc. Net Income History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$76.6M
FY2025
5-year range
-$76.6M / -$24.5M
FY2021-FY2025
Trend
-14.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -$24M to -$77M over the past 2 years.
Based on SEC 10-K filings.
-$77M in FY2025.
Declined from -$24M to -$77M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net income decreased 14.3% year-over-year.
- Peak net income was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -3.86 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$76.6M | -14.3% |
| FY2024 | -$67.0M | -173.6% |
| FY2023 | -$24.5M | +30.2% |
| FY2022 | -$35.1M | +17.8% |
| FY2021 | -$42.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026